Inhibition of protein synthesis by the nonstructural proteins NS4A and NS4B of hepatitis C virus

Virus Research

Volumn 90, Issue 1-2, 2002, Pages 119-131

  Florese, Ruth H ^a   Nagano Fujii, Motoko ^a   Iwanaga, Yasuhiro ^a   Hidajat, Rachmat ^a   Hotta, Hak ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Degradation; Endoplasmic reticulum stress; Hepatitis C virus; NS4A; NS4B; Translational inhibition

Indexed keywords

AMINO ACID; CELL PROTEIN; CORE PROTEIN; PROTEIN; PROTEIN NS4A; PROTEIN NSAB; PROTEIN P53; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN MOTIF; PROTEIN SYNTHESIS; TRANSLATION INITIATION; VIRUS HYBRID; VIRUS TRANSCRIPTION;

3T3 CELLS; AMINO ACID SEQUENCE; ANIMALS; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; HEPACIVIRUS; HUMANS; MICE; MOLECULAR SEQUENCE DATA; PROTEIN BIOSYNTHESIS; TUMOR CELLS, CULTURED; VIRAL NONSTRUCTURAL PROTEINS; VIRAL PROTEINS;

HEPATITIS C VIRUS;

EID: 0036891628     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-1702(02)00146-6     Document Type: Article

References (59)

1. Apichartpiyakul C., Chittivudikarn C., Miyajima H., Homma M., Hotta H. Analysis of hepatitis C virus isolates among healthy blood donors and drug addicts in Chiang Mai, Thailand. J. Clin. Microbiol. 32:1994;2276-2279.
2. Bartenschlager R., Lohmann V., Wilkinson T., Koch J.O. Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation. J. Virol. 69:1995;7519-7528.
3. Bays N.W., Gardner R.G., Seelig L.P., Joazeiro C.A., Hampton R.Y. Hrd1p/Der3p is a membrane-anchored ubiquitin ligase required for ER-associated degradation. Nat. Cell Biol. 3:2001;25-29.
4. Bertolotti A., Zhang Y., Hendershot L.M., Harding H.P., Ron D. Dynamic Interaction of BiP and ER stress transducers in the unfolded-protein response. Nat. Cell Biol. 2:2000;326-332.
5. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
6. Darke P.L., Jacobs A.R., Waxman L., Kuo L.C. Inhibition of hepatitis C virus NS2/3 processing by NS4A peptides: Implications for control of viral processing. J. Biol. Chem. 274:1999;34511-34514.
7. Doi H., Apichartpiyakul C., Ohba K.I., Mizokami M., Hotta H. Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand and identification of novel subtypes of HCV major type 6. J. Clin. Microbiol. 34:1996;569-574.
8. el-Deiry W.S., Tokino T., Waldman T., Oliner J.D., Velculescu V.E., Burrell M., Hill D.E., Healy E., Rees J.L., Hamilton S.R. Topological control of p21WAF1/CIP1 expression in normal and neoplastic tissues. Cancer Res. 55:1995;2910-2911.
9. Failla C., Tomei L., De Francesco R. An amino terminal domain of the hepatitis C virus NS3 protease is essential for interaction with NS4A. J. Virol. 69:1995;1769-1777.
10. Farci P., Shimoda A., Coiana A., Diaz G., Peddis G., Melpolder J.C., Strazzera A., Chien D.Y., Munoz S.J., Balestrieri A., Purcell R.H., Alter H.J. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science. 288:2000;339-342.
11. Flajolet M., Rotondo G., Daviet L., Bergametti F., Inchauspe G., Tiollais P., Transy C., Legrain P. A genomic approach of hepatitis C virus generates a protein interaction map. Gene. 242:2000;369-379.
12. Fujita T., Muramatsu S., Itoh M., Hotta H. Suppression of actinomycin D-induced apoptosis by the NS3 protein of hepatitis C virus. Biochem. Biophys. Res. Commun. 229:1996;825-831.
13. Gordon S.C., Bayati N., Silverman A.L. Clinical outcome of hepatitis C as a function of mode of transmission. Hepatology. 28:1998;562-567.
14. Grakoui A., Wychowski C., Lin C., Feinstone S.M., Rice C.M. Expression and identification of hepatitis C virus polyprotein cleavage products. J. Virol. 67:1993;1385-1395.
15. Harding H.P., Zhang Y., Ron D. Protein translation and folding are coupled by an endoplasmic reticulum-resident kinase. Nature. 397:1999;271-274.
16. Harding H.P., Zhang Y., Bertolotti A., Zeng H., Ron D. Perk is essential for translational regulation and cell survival during the unfolded protein response. Mol. Cell. 5:2000;897-904.
17. Hijikata M., Kato N., Ootsuyama Y., Nakagawa M., Shimotohno K. Gene mapping of the putative structural region of the hepatitis C virus genome by in vitro processing analysis. Proc. Natl. Acad. Sci. USA. 88:1991;5547-5551.
18. Hotta H., Miyamoto H., Hara I., Takahashi N., Homma M. Genomic structure of the ME491/CD63 antigen gene and functional analysis of the 5′-flanking regulatory sequences. Biochem. Biophys. Res. Commun. 185:1992;436-442.
19. Houghton M. Hepatitis C viruses. Fields B.N., Knipe D.M., Howley P.M. Virology. 3rd ed. 1996;1035-1058 Lippincott-Raven, Philadelphia, PA.
20. Hügle T., Fehrmann F., Bieck E., Kohara M., Krausslich H.G., Rice C.M., Blum H.E., Moradpour D. The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. Virology. 284:2001;70-81.
21. Ichii Y., Fukunaga R., Shiojiri S., Sokawa Y. Mouse 2-5A synthetase cDNA: nucleotide sequence and comparison to human 2-5A synthetase. Nucleic Acids Res. 14:1986;10117.
22. Ishido S., Hotta H. Complex formation of the nonstructural protein 3 of hepatitis C virus with the p53 tumor suppressor. FEBS Lett. 438:1998;258-262.
23. Ishido S., Muramatsu S., Fujita T., Iwanaga Y., Tong W.Y., Katayama Y., Itoh M., Hotta H. Wild-type, but not mutant-type, p53 enhances nuclear accumulation of the NS3 protein of hepatitis C virus. Biochem. Biophys. Res. Commun. 230:1997;431-436.
24. Ishido S., Fujita T., Hotta H. Complex formation of NS5B with NS3 and NS4A proteins of hepatitis C virus. Biochem. Biophys. Res. Commun. 244:1998;35-40.
25. Iwawaki T., Hosoda A., Okuda T., Kamigori Y., Nomura-Furuwatari C., Kimata Y., Tsuru A., Kohno K. Translational control by the ER transmembrane kinase/ribonuclease IRE1 under ER stress. Nat. Cell Biol. 3:2001;158-164.
26. Kaneko T., Tanji Y., Satoh S., Hijikata M., Asabe S., Kimura K., Shimotohno K. Production of two phosphoproteins from the NS5A region of the hepatitis C genome. Biochem. Biophys. Res. Commun. 205:1994;320-326.
27. Kato J., Kato N., Yoshida H., Ono-Nita S.K., Shiratori Y., Omata M. Hepatitis C virus NS4A and NS4B proteins suppress translation in vivo. J. Med. Virol. 66:2002;187-199.
28. Kim J.L., Morgestern K.A., Lin C., Fox T., Dwyer M.D., Landro J.A., Chambers S.P., Markland W., Lepre C.A., O' Malley E.T., Harbeson S.L., Rice C.M., Murcko M.A., Caron P.R., Thomson J.A. Crystal structure of hepatitis C virus NS3 protease domain complexed with a synthetic NS4A cofactor peptide. Cell. 87:1996;343-355.
29. Kim J.E., Song W.K., Chung K.M., Back S.H., Jang S.K. Subcellular localization of hepatitis C viral proteins in mammalian cells. Arch. Virol. 144:1999;329-343.
30. Knipe D.M. Virus-host cell interactions. Fields B.N., Knipe D.M., Howley P.M. Virology. 3rd ed. 1996;273-299 Lippincott-Raven, Philadelphia, PA.
31. Koch J.O., Bartenschlager R. Modulation of hepatitis C virus NS5A hyperphosphorylation by nonstructural proteins NS3, NS4A and NS4B. J. Virol. 73:1999;7138-7146.
32. Lauer G.M., Walker B.D. Hepatitis C virus infection. N. Engl. J. Med. 345:2001;41-52.
33. Lin C., Thomson J.A., Rice C.M. A central region in the hepatitis C virus NS4A protein allows formation of an active NS3-NS4A serine proteinase complex in vivo and in vitro. J. Virol. 69:1995;4373-4380.
34. Lin C., Wu J.W., Hsiao K., Su M.S. The hepatitis C virus NS4A protein: interactions with the NS4B and NS5A proteins. J. Virol. 71:1997;6465-6471.
35. Mamiya N., Worman H.J. Hepatitis C virus core protein binds to a DEAD box RNA helicase. J. Biol. Chem. 274:1999;15751-15756.
36. Mellor, J., Holmes, E.C., Jarvis, L.M., Yap, P.L. Simmonds, P., The International HCV Collaborative Study Group, 1995. Investigation of the pattern of hepatitis C virus sequence diversity in different geographical regions: Implications for virus classification. J. Gen. Virol. 76, 2493-507.
37. Min J., Shukla H., Kozono H., Bronson S.K., Weissman S.M., Chaplin D.D. A novel CREB family gene telomeric of HLA-DRA in the HLA complex. Genomics. 30:1995;149-156.
38. Mizushima H., Hijikata M., Asabe S., Hirota M., Kimura K., Shimotohno K. Two hepatitis C virus glycoprotein E2 products with different C termini. J. Virol. 68:1994;6215-6222.
39. Mori K. Tripartite management of unfolded proteins in the endoplasmic reticulum. Cell. 101:2000;451-454.
40. Muramatsu S., Ishido S., Fujita T., Itoh M., Hotta H. Nuclear localization of the NS3 protein of hepatitis C virus and factors affecting the localization. J. Virol. 71:1997;4954-4961.
41. Neddermann P., Clementi A., De Francesco R. Hyperphosphorylation of the hepatitis C virus NS5A protein requires an active NS3 protease, NS4A, NS4B and NS5A encoded on the same polyprotein. J. Virol. 73:1999;9984-9991.
42. Park J.S., Yang J.M., Min M.K. Hepatitis C virus nonstructural protein 4B transforms NIH3T3 cells in cooperation with the Ha-ras oncogene. Biochem. Biophys. Res. Commun. 267:2000;581-587.
43. Patil C., Walter P. Intracellular signalling from the endoplasmic reticulum to the nucleus: the unfolded protein response in yeast and mammals. Curr. Opin. Cell Biol. 13:2001;349-356.
44. Qu L., McMullan L.K., Rice C.M. Isolation and characterization of noncytopathic pestivirus mutants reveals a role for nonstructural protein NS4B in viral cytopathogenicity. J. Virol. 75:2001;10651-10662.
45. Reed K.E., Rice C.M. Overview of hepatitis C virus genome structure, polyprotein processing and protein properties. Curr. Top. Microbiol. Immunol. 242:2000;55-84.
46. Robertson B., Myers G., Howard C., Brettin T., Bukh J., Gaschen B., Gojobori T., Maertens G., Mizokami M., Nainan O., Netesov S., Nishioka K., Shin-i T., Simmonds P., Smith D., Stuyver L., Weiner A. Classification, nomenclature and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. Arch. Virol. 143:1998;2493-2503.
47. Satoh S., Tanji Y., Hijikata M., Kimura K., Shimotohno K. The N-terminal region of hepatitis C virus nonstructural protein 3 (NS3) is essential for stable complex formation with NS4A. J. Virol. 69:1995;4255-4260.
48. Seeff L. Natural history of hepatitis C. Hepatology. 26:1997;21S-28S.
49. Shimizu Y., Yamaji K., Masuho Y., Yokota T., Inoue H., Sudo K., Satoh S., Shimotohno K. Identification of the sequence on NS4A required for enhanced cleavage of the NS5A/5B site by hepatitis C virus NS3 protease. J. Virol. 70:1996;27-132.
50. Shimotohno K. Hepatitis C virus as a causative agent of hepatocellular carcinoma. Intervirology. 38:1995;162-169.
51. Soetjipto, Handajani, R., Lusida, M.I., Darmadi, S., Adi, P., Soemarto, Ishido, S., Katayama, Y., Hotta, H., 1996. Differential prevalence of hepatitis C virus subtypes in healthy blood donors, patients on maintenance hemodialysis, and patients with hepatocellular carcinoma in Surabaya, Indonesia, J. Clin. Microbiol. 34, 2875-2880.
52. Song J., Fujii M., Wang F., Itoh M., Hotta H. The NS5A protein of hepatitis C virus partially inhibits the antiviral activity of interferon. J. Gen. Virol. 80:1999;879-886.
53. Tanji Y., Kaneko T., Satoh S., Shimotohno K. Phosphorylation of hepatitis C virus-encoded nonstructural protein NS5A. J. Virol. 69:1995;3980-3986.
54. Travers K.J., Patil C.K., Wodicka L., Lockhart D.J., Weissman J.S., Walter P. Functional and genomic analyses reveal an essential coordination between the unfolded protein response and ER-associated degradation. Cell. 101:2000;249-258.
55. Wang F., Yoshida I., Takamatsu M., Ishido S., Fujita T., Oka K., Hotta H. Complex formation between hepatitis C virus Core protein and p21Waf1/Cip1/Sdi1. Biochem. Biophys. Res. Commun. 273:2000;479-484.
56. Wolfe S. Molecular and Cellular Biology. 1993;720-721 Wadsworth Inc, Belmont, CA.
57. Wölk B., Sansonno D., Krausslich H.G., Dammacco F., Rice C.M., Blum H.E., Moradpour D. Subcellular localization, stability and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline regulated cell lines. J. Virol. 74:2000;2293-2304.
58. Yoshida I., Oka K., Hidajat R., Fujii-Nagano M., Ishido S., Hotta H. Inhibition of p21/Waf1/Cip1/Sdi1 expression by hepatitis C virus core protein. Microbiol. Immunol. 45:2001;689-697.
59. Zhou A., Hassel B.A., Silverman R.H. Expression cloning of 2-5A dependent RNAse: a uniquely regulated mediator of interferon action. Cell. 72:1993;753-765.